Research progress of neoadjuvant chemotherapy for esophageal squamous cell carcinoma
10.3760/cma.j.issn.1673-9752.2019.06.017
- VernacularTitle:食管鳞癌新辅助化疗的研究进展
- Author:
Liang CHENG
1
;
Maoyong FU
;
Hao YANG
;
Wei GAO
;
Zhonghui JIANG
Author Information
1. 川北医学院附属医院胸心外科
- Keywords:
Esophageal neoplasms;
Squamous cell carcinoma;
Neoadjuvant chemotherapy;
Surgical procedures,operative
- From:
Chinese Journal of Digestive Surgery
2019;18(6):604-606
- CountryChina
- Language:Chinese
-
Abstract:
China is a high risk region of esophageal cancer in the world,and 95％ of the esophageal cancer is the squamous cell carcinoma.Surgery is the main therapy for esophageal squamous cell carcinoma,however,the efficacy of single surgery for locally advanced esophageal squamous cell carcinoma is unsatisfactory.Compared with postoperative adjuvant treatment,neoadjuvant chemotherapy may reduce tumor volume,increase surgical resectability,eliminate subclinical metastases,prolong survival time and improve prognosis of patients with esophageal squamous cell carcinoma.Through combining recent evidence-based medicine,the authors review research progress of new adjuvant chemotherapy for esophageal squamous cell carcinoma.
